Aehr Test Systems（AYB）株式概要Aehr Test Systems, Inc.は、ウェハレベル、シングルドダイ、パッケージ部品フォーム、およびインストールシステムにおけるテスト、バーンイン、半導体デバイスのテストソリューションを世界中に提供しています。 詳細AYB ファンダメンタル分析スノーフレーク・スコア評価0/6将来の成長2/6過去の実績0/6財務の健全性6/6配当金0/6報酬収益は年間44.68%増加すると予測されています リスク分析German市場と比較して、過去 3 か月間の株価の変動が非常に大きい過去3か月間に大規模なインサイダー売却が発生 すべてのリスクチェックを見るAYB Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair Value€Current Price€73.10130.7% 割高 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-11m287m2016201920222025202620282031Revenue US$286.9mEarnings US$44.8mAdvancedSet Fair ValueView all narrativesAehr Test Systems, Inc. 競合他社SiltronicSymbol: XTRA:WAFMarket cap: €2.7bAIXTRONSymbol: XTRA:AIXAMarket cap: €5.9bSUSS MicroTecSymbol: XTRA:SMHNMarket cap: €1.7bPVA TePlaSymbol: XTRA:TPEMarket cap: €917.8m価格と性能株価の高値、安値、推移の概要Aehr Test Systems過去の株価現在の株価US$73.1052週高値US$93.0052週安値US$7.31ベータ3.271ヶ月の変化-6.26%3ヶ月変化195.00%1年変化854.31%3年間の変化162.95%5年間の変化4,251.19%IPOからの変化1,933.95%最新ニュースBoard Change • 15hInsufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. Independent Director Fariba Danesh was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.お知らせ • Apr 09Aehr Test Systems, Inc. has filed a Follow-on Equity Offering in the amount of $60 million.Aehr Test Systems, Inc. has filed a Follow-on Equity Offering in the amount of $60 million. Security Name: Common Stock Security Type: Common Stock Transaction Features: At the Market Offeringお知らせ • Mar 30Aehr Test Systems, Inc. to Report Q3, 2026 Results on Apr 07, 2026Aehr Test Systems, Inc. announced that they will report Q3, 2026 results After-Market on Apr 07, 2026お知らせ • Jan 09Aehr Test Systems, Inc. Reinstates Earnings Guidance for the Second Half of Fiscal 2026Aehr Test Systems, Inc. reinstated earnings guidance for the second half of fiscal 2026. For the period, which began November 29, 2025 and ends this May 29, 2026, Aehr expects revenue between $25 million and $30 million.お知らせ • Dec 30Aehr Test Systems, Inc. to Report Q2, 2026 Results on Jan 08, 2026Aehr Test Systems, Inc. announced that they will report Q2, 2026 results After-Market on Jan 08, 2026お知らせ • Sep 29Aehr Test Systems, Inc. to Report Q1, 2026 Results on Oct 06, 2025Aehr Test Systems, Inc. announced that they will report Q1, 2026 results at 4:00 PM, US Eastern Standard Time on Oct 06, 2025最新情報をもっと見るRecent updatesBoard Change • 15hInsufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. Independent Director Fariba Danesh was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.お知らせ • Apr 09Aehr Test Systems, Inc. has filed a Follow-on Equity Offering in the amount of $60 million.Aehr Test Systems, Inc. has filed a Follow-on Equity Offering in the amount of $60 million. Security Name: Common Stock Security Type: Common Stock Transaction Features: At the Market Offeringお知らせ • Mar 30Aehr Test Systems, Inc. to Report Q3, 2026 Results on Apr 07, 2026Aehr Test Systems, Inc. announced that they will report Q3, 2026 results After-Market on Apr 07, 2026お知らせ • Jan 09Aehr Test Systems, Inc. Reinstates Earnings Guidance for the Second Half of Fiscal 2026Aehr Test Systems, Inc. reinstated earnings guidance for the second half of fiscal 2026. For the period, which began November 29, 2025 and ends this May 29, 2026, Aehr expects revenue between $25 million and $30 million.お知らせ • Dec 30Aehr Test Systems, Inc. to Report Q2, 2026 Results on Jan 08, 2026Aehr Test Systems, Inc. announced that they will report Q2, 2026 results After-Market on Jan 08, 2026お知らせ • Sep 29Aehr Test Systems, Inc. to Report Q1, 2026 Results on Oct 06, 2025Aehr Test Systems, Inc. announced that they will report Q1, 2026 results at 4:00 PM, US Eastern Standard Time on Oct 06, 2025お知らせ • Sep 11Aehr Test Systems, Inc., Annual General Meeting, Oct 20, 2025Aehr Test Systems, Inc., Annual General Meeting, Oct 20, 2025. Location: 400kato terrace, california 94539, fremont United Statesお知らせ • Jun 30Aehr Test Systems, Inc. to Report Q4, 2025 Results on Jul 08, 2025Aehr Test Systems, Inc. announced that they will report Q4, 2025 results After-Market on Jul 08, 2025お知らせ • Mar 28Aehr Test Systems, Inc. to Report Q3, 2025 Results on Apr 08, 2025Aehr Test Systems, Inc. announced that they will report Q3, 2025 results at 4:00 PM, US Eastern Standard Time on Apr 08, 2025お知らせ • Jan 14Aehr Test Systems Reiterates Earnings Guidance for Fiscal Year Ending May 30, 2025For the fiscal year ending May 30, 2025, Aehr Test Systems, Inc. reiterated its previously provided guidance for total revenue of at least $70 million.お知らせ • Jan 01Aehr Test Systems, Inc. to Report Q2, 2025 Results on Jan 13, 2025Aehr Test Systems, Inc. announced that they will report Q2, 2025 results at 4:00 PM, US Eastern Standard Time on Jan 13, 2025Board Change • Dec 30Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. Independent Director Fariba Danesh was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.お知らせ • Dec 06Gewirtz & Grossman LLC Notifies Class Action Lawsuit Filed Against Aehr Test Systems, IncGewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Aehr Test Systems, Inc. and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Aehr securities between January 9, 2024 and March 24, 2024, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site. The Complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that: (1) contrary to prior representations to investors, Aehr was continuing to experience substantial delays in customer orders; (2) the foregoing issue was likely to have a material negative impact on the Company's revenue growth; (3) accordingly, the Company's business and/or financial prospects were overstated; and (4) as a result, the Company's public statements were materially false and misleading at all relevant times. A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm’s site: bgandg.com/AEHR. or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 332-239-2660. If you suffered a loss in Aehr you have until February 3, 2025, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff. We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys’ fees, usually a percentage of the total recovery, only if we are successful. Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide. Attorney advertising. Prior results do not guarantee similar outcomes.Valuation Update With 7 Day Price Move • Nov 01Investor sentiment deteriorates as stock falls 21%After last week's 21% share price decline to €12.74, the stock trades at a trailing P/E ratio of 14.3x. Average forward P/E is 13x in the Semiconductor industry in Germany. Total loss to shareholders of 44% over the past three years.お知らせ • Oct 16Aehr Test Systems, Inc. has filed a Follow-on Equity Offering in the amount of $40 million.Aehr Test Systems, Inc. has filed a Follow-on Equity Offering in the amount of $40 million. Security Name: Common Stock Security Type: Common Stock Transaction Features: At the Market OfferingReported Earnings • Oct 11First quarter 2025 earnings released: EPS: US$0.023 (vs US$0.16 in 1Q 2024)First quarter 2025 results: EPS: US$0.023 (down from US$0.16 in 1Q 2024). Revenue: US$13.1m (down 36% from 1Q 2024). Net income: US$660.0k (down 86% from 1Q 2024). Profit margin: 5.0% (down from 23% in 1Q 2024). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 27% p.a. on average during the next 3 years, compared to a 8.0% growth forecast for the Semiconductor industry in Germany. Over the last 3 years on average, earnings per share has increased by 66% per year but the company’s share price has fallen by 12% per year, which means it is significantly lagging earnings.お知らせ • Oct 11Aehr Test Systems, Inc. Reaffirms Earnings Guidance for the Fiscal Year Ending May 30, 2025Aehr Test Systems, Inc. reaffirms earnings guidance for the fiscal year ending May 30, 2025. For the fiscal year ending May 30, 2025, Aehr is reiterating its previously provided guidance for total revenue of at least $70 million and net profit before taxes of at least 10% of revenue.お知らせ • Oct 02Aehr Test Systems, Inc. to Report Q1, 2025 Results on Oct 10, 2024Aehr Test Systems, Inc. announced that they will report Q1, 2025 results After-Market on Oct 10, 2024お知らせ • Sep 12Aehr Test Systems, Inc., Annual General Meeting, Oct 21, 2024Aehr Test Systems, Inc., Annual General Meeting, Oct 21, 2024. Location: 400 kato terrace, california 94539, fremont United StatesValuation Update With 7 Day Price Move • Aug 30Investor sentiment improves as stock rises 15%After last week's 15% share price gain to €13.73, the stock trades at a trailing P/E ratio of 13.6x. Average forward P/E is 14x in the Semiconductor industry in Germany. Total returns to shareholders of 97% over the past three years.Valuation Update With 7 Day Price Move • Aug 06Investor sentiment deteriorates as stock falls 21%After last week's 21% share price decline to €12.93, the stock trades at a trailing P/E ratio of 13.4x. Average forward P/E is 14x in the Semiconductor industry in Germany. Total returns to shareholders of 165% over the past three years.Recent Insider Transactions • Aug 01Independent Director recently sold €172k worth of stockOn the 30th of July, Fariba Danesh sold around 10k shares on-market at roughly €17.21 per share. This transaction amounted to 70% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of €887k more than they bought in the last 12 months.お知らせ • Jul 17+ 1 more updateAehr Test Systems (NasdaqCM:AEHR) agreed to acquire Incal Technology, Inc for $23.1.Aehr Test Systems (NasdaqCM:AEHR) agreed to acquire Incal Technology, Inc for $23.1 on July 15, 2024. A cash consideration of $14 million will be paid by Aehr Test Systems. The consideration consists of 0.55 million common equity of Aehr Test Systems to be issued for common equity of Incal Technology, Inc. The transaction has been approved by the board of directors of both companies and the Acquisition is expected to close within 60 days, subject to customary closing conditions. The transaction is subject to certain post-closing adjustments with respect to working capital. Latham & Watkins LLP acted as legal advisor for Aehr Test Systems.Valuation Update With 7 Day Price Move • Jul 12Investor sentiment improves as stock rises 39%After last week's 39% share price gain to €13.92, the stock trades at a trailing P/E ratio of 28.4x. Average forward P/E is 17x in the Semiconductor industry in Germany. Total returns to shareholders of 338% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €8.58 per share.Buy Or Sell Opportunity • Jul 09Now 33% overvalued after recent price riseOver the last 90 days, the stock has risen 3.9% to €11.63. The fair value is estimated to be €8.72, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 48% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to decline by 6.6% in a year. Earnings are forecast to decline by 22% in the next year.お知らせ • Jul 04Aehr Test Systems to Report Q4, 2024 Results on Jul 16, 2024Aehr Test Systems announced that they will report Q4, 2024 results After-Market on Jul 16, 2024Buy Or Sell Opportunity • Jul 01Now 20% overvaluedOver the last 90 days, the stock has fallen 6.0% to €10.36. The fair value is estimated to be €8.61, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 48% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to decline by 6.6% in a year. Earnings are forecast to decline by 22% in the next year.Buy Or Sell Opportunity • Jun 27Now 21% overvaluedOver the last 90 days, the stock has fallen 12% to €9.95. The fair value is estimated to be €8.25, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 48% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to decline by 6.6% in a year. Earnings are forecast to decline by 22% in the next year.Valuation Update With 7 Day Price Move • Jun 26Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to €9.45, the stock trades at a trailing P/E ratio of 19.7x. Average forward P/E is 14x in the Semiconductor industry in Germany. Total returns to shareholders of 318% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €8.31 per share.Valuation Update With 7 Day Price Move • Jun 06Investor sentiment improves as stock rises 18%After last week's 18% share price gain to €11.55, the stock trades at a trailing P/E ratio of 25.1x. Average forward P/E is 15x in the Semiconductor industry in Germany. Total returns to shareholders of 439% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €7.77 per share.Board Change • Jun 02Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. Independent Director Fariba Danesh was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Buy Or Sell Opportunity • Jun 01Now 27% overvaluedOver the last 90 days, the stock has fallen 30% to €10.50. The fair value is estimated to be €8.26, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 48% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to decline by 6.6% in a year. Earnings are forecast to decline by 22% in the next year.Buy Or Sell Opportunity • May 11Now 22% overvaluedOver the last 90 days, the stock has fallen 33% to €10.46. The fair value is estimated to be €8.60, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 48% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to decline by 6.6% in a year. Earnings are forecast to decline by 22% in the next year.New Risk • Apr 12New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 14% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Earnings are forecast to decline by an average of 14% per year for the foreseeable future. High level of non-cash earnings (34% accrual ratio). Minor Risks Shareholders have been diluted in the past year (4.2% increase in shares outstanding). Significant insider selling over the past 3 months (€140k sold).Buy Or Sell Opportunity • Apr 10Now 25% overvaluedOver the last 90 days, the stock has fallen 31% to €11.20. The fair value is estimated to be €8.96, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 48% over the last 3 years. Meanwhile, the company has become profitable.Reported Earnings • Apr 10Third quarter 2024 earnings released: US$0.051 loss per share (vs US$0.15 profit in 3Q 2023)Third quarter 2024 results: US$0.051 loss per share (down from US$0.15 profit in 3Q 2023). Revenue: US$7.56m (down 56% from 3Q 2023). Net loss: US$1.47m (down 136% from profit in 3Q 2023). Revenue is expected to decline by 5.7% p.a. on average during the next 2 years, while revenues in the Semiconductor industry in Germany are expected to grow by 8.3%. Over the last 3 years on average, earnings per share has increased by 83% per year whereas the company’s share price has increased by 79% per year.お知らせ • Apr 10Aehr Test Systems Provides Earnings Guidance for the Fiscal Year Ending May 31, 2024Aehr Test Systems provides earnings guidance for the fiscal year ending May 31, 2024. For the period, the company reiterating its previously provided guidance for total revenue of greater than $65 million and GAAP net income of approximately $11 million or more, or $0.38 per diluted share.Valuation Update With 7 Day Price Move • Mar 30Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to €11.33, the stock trades at a trailing P/E ratio of 17x. Average forward P/E is 14x in the Semiconductor industry in Germany. Total returns to shareholders of 434% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €6.68 per share.お知らせ • Mar 26Aehr Test Systems to Report Q3, 2024 Results on Apr 09, 2024Aehr Test Systems announced that they will report Q3, 2024 results on Apr 09, 2024Valuation Update With 7 Day Price Move • Mar 16Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to €13.03, the stock trades at a trailing P/E ratio of 19.5x. Average forward P/E is 16x in the Semiconductor industry in Germany. Total returns to shareholders of 515% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €6.71 per share.Valuation Update With 7 Day Price Move • Feb 09Investor sentiment improves as stock rises 17%After last week's 17% share price gain to €15.96, the stock trades at a trailing P/E ratio of 23.1x. Average forward P/E is 19x in the Semiconductor industry in Germany. Total returns to shareholders of 571% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €7.08 per share.New Risk • Jan 22New minor risk - Insider sellingThere has been significant insider selling in the company's shares over the past 3 months. Total value of shares sold: €147k This is considered a minor risk. There are several reasons why an insider may be selling, including to cover a tax obligation or pay for some other expense. However, we generally consider it a negative if insiders have been selling, especially if they do so below the current price. It implies that they considered a lower price to be reasonable. This is a weak signal, but if there is a pattern of unexplained selling, it can be a sign the insider believes the company's stock is overpriced. Note: We only include open market transactions and private dispositions of directly owned stock by individuals, not by corporations or trusts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). High level of non-cash earnings (52% accrual ratio). Minor Risks Shareholders have been diluted in the past year (3.9% increase in shares outstanding). Significant insider selling over the past 3 months (€147k sold).Recent Insider Transactions • Jan 22President recently sold €78k worth of stockOn the 18th of January, Gayn Erickson sold around 5k shares on-market at roughly €16.01 per share. This transaction amounted to 1.6% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Gayn has been a net seller over the last 12 months, reducing personal holdings by €5.7m.Reported Earnings • Jan 10Second quarter 2024 earnings released: EPS: US$0.21 (vs US$0.14 in 2Q 2023)Second quarter 2024 results: EPS: US$0.21 (up from US$0.14 in 2Q 2023). Revenue: US$21.4m (up 45% from 2Q 2023). Net income: US$6.09m (up 64% from 2Q 2023). Profit margin: 28% (up from 25% in 2Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 214% p.a. on average during the next 2 years, compared to a 8.0% growth forecast for the Semiconductor industry in Germany. Over the last 3 years on average, earnings per share has increased by 99% per year but the company’s share price has increased by 122% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Jan 10Aehr Test Systems Provides Earnings Guidance for the Fiscal Year Ending May 31, 2024Aehr Test Systems provided earnings guidance For the fiscal year ending May 31, 2024. For the year, the company is revising its expected full year total revenue to be between $75 million and $85 million, representing growth of 15% to 30% year over year, and GAAP net income of between 20% and 25% of revenue.Valuation Update With 7 Day Price Move • Nov 03Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to €23.35, the stock trades at a trailing P/E ratio of 38.2x. Average forward P/E is 15x in the Semiconductor industry in Germany. Total returns to shareholders of 2,271% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €9.44 per share.お知らせ • Oct 21Aehr Test Systems Announces Resignation of Rhea J. Posedel from Corporate Governance and Nominating CommitteeAehr Test Systems announced that Rhea J. Posedel resigned from the Corporate Governance and Nominating Committee of AEHR Test Systems Inc. (the “Company”) effective October 19, 2023. Although Mr. Posedel will continue to stand for election at the Company’s Annual Meeting of Shareholders (to be held on October 23, 2023, at 4:00 p.m.), he will not in the future be nominated or appointed to any of the Company’s committees made up of independent directors including the Corporate Governance and Nominating Committee, Audit Committee, and the Compensation Committee. The new chair of the Corporate Governance and Nominating Committee will be appointed at the upcoming meeting of the Board of Directors (the “Board”) on October 23, 2023.Valuation Update With 7 Day Price Move • Oct 19Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to €30.76, the stock trades at a trailing P/E ratio of 49x. Average forward P/E is 14x in the Semiconductor industry in Germany. Total returns to shareholders of 2,775% over the past three years.Reported Earnings • Oct 06First quarter 2024 earnings released: EPS: US$0.16 (vs US$0.022 in 1Q 2023)First quarter 2024 results: EPS: US$0.16 (up from US$0.022 in 1Q 2023). Revenue: US$20.6m (up 93% from 1Q 2023). Net income: US$4.67m (up US$4.09m from 1Q 2023). Profit margin: 23% (up from 5.5% in 1Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 39% p.a. on average during the next 3 years, compared to a 8.0% growth forecast for the Semiconductor industry in Germany. Over the last 3 years on average, earnings per share has increased by 106% per year but the company’s share price has increased by 236% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Oct 06Aehr Test Systems Reiterates Earnings Guidance for the Fiscal Year Ending May 31, 2024Aehr Test Systems reiterated earnings guidance for the fiscal year ending May 31, 2024. For the year, the company expects total revenue to be at least $100 million, representing growth of over 50% year over year, and GAAP net income of at least $28 million, representing earnings growth of greater than 90% year over year.お知らせ • Sep 27Aehr Test Systems to Report Q1, 2024 Results on Oct 05, 2023Aehr Test Systems announced that they will report Q1, 2024 results at 5:00 PM, US Eastern Standard Time on Oct 05, 2023お知らせ • Sep 14Aehr Test Systems, Annual General Meeting, Oct 23, 2023Aehr Test Systems, Annual General Meeting, Oct 23, 2023, at 16:00 Pacific Daylight. Location: corporate headquarters located at 400 Kato Terrace Fremont California United States Agenda: to consider and elect six directors of the company to hold office until the next annual meeting or the election of their successors; to consider and ratify the selection of bpm llp as the company’s independent registered public accounting firm for the fiscal year ending may 31, 2024; to consider and approve, on an advisory (non-binding) basis, the compensation of the company’s named executive officers; to transact such other business as may properly come before the annual meeting or any postponements or adjournments thereof.Reported Earnings • Aug 30Full year 2023 earnings released: EPS: US$0.52 (vs US$0.36 in FY 2022)Full year 2023 results: EPS: US$0.52 (up from US$0.36 in FY 2022). Revenue: US$65.0m (up 28% from FY 2022). Net income: US$14.6m (up 54% from FY 2022). Profit margin: 22% (up from 19% in FY 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 38% p.a. on average during the next 3 years, compared to a 7.9% growth forecast for the Semiconductor industry in Germany. Over the last 3 years on average, earnings per share has increased by 110% per year but the company’s share price has increased by 209% per year, which means it is tracking significantly ahead of earnings growth.Valuation Update With 7 Day Price Move • Aug 18Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to €37.53, the stock trades at a trailing P/E ratio of 77.7x. Average forward P/E is 15x in the Semiconductor industry in Germany. Total returns to shareholders of 2,260% over the past three years.Recent Insider Transactions • Jul 21President recently sold €5.7m worth of stockOn the 17th of July, Gayn Erickson sold around 124k shares on-market at roughly €45.65 per share. This transaction amounted to 29% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Gayn has been a net seller over the last 12 months, reducing personal holdings by €7.4m.Reported Earnings • Jul 14Full year 2023 earnings released: EPS: US$0.52 (vs US$0.36 in FY 2022)Full year 2023 results: EPS: US$0.52 (up from US$0.36 in FY 2022). Revenue: US$65.0m (up 28% from FY 2022). Net income: US$14.6m (up 54% from FY 2022). Profit margin: 22% (up from 19% in FY 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 38% p.a. on average during the next 3 years, compared to a 8.3% growth forecast for the Semiconductor industry in Germany. Over the last 3 years on average, earnings per share has increased by 110% per year but the company’s share price has increased by 194% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Jul 14Aehr Test Systems Provides Earnings Guidance for the Year 2024For the fiscal year ending May 31, 2024, Aehr Test Systems expects total revenue to be at least $100 million, representing growth of over 50% year over year, and GAAP net income of at least $28 million, representing earnings growth of greater than 90% year over year.お知らせ • Jul 06Aehr Test Systems to Report Q4, 2023 Results on Jul 13, 2023Aehr Test Systems announced that they will report Q4, 2023 results at 4:00 PM, US Eastern Standard Time on Jul 13, 2023お知らせ • Jun 01Aehr Test Systems Appoints Chris Siu, as Chief Financial Officer Effective June 1, 2023Aehr Test Systems announced the appointment of Chris Siu as the Company’s Chief Financial Officer, Executive Vice President of Finance, and Secretary effective June 1, 2023. He will succeed Ken Spink, who previously announced his planned retirement after 15 years with the Company. Mr. Spink will stay on through the completion of Aehr’s fiscal 2023 year that ends May 31, 2023 and annual 10-K filing to ensure an orderly transition. Mr. Siu brings more than 27 years of finance and accounting experience in the semiconductor, medical equipment, and public accounting industries. Before joining Aehr Test Systems, he most recently served four years in senior finance executive positions at publicly traded Ultra Clean Technologies, a global leading developer and supplier of critical subsystems, components and parts, and ultra-high purity clean and analytical services primarily for the semiconductor and semiconductor equipment industry, including Senior Vice President of Finance, Corporate Treasurer, and Chief Accounting Officer. Prior to Ultra Clean Technologies, Mr. Siu held senior management roles at PDF Solutions and also GlobalFoundries, a multinational semiconductor manufacturing company, where he served for eight years including leading all global accounting functions as Corporate Controller for four years. He was also Chief Accounting Officer and Director of Finance at semiconductor company Trident Microsystems and served in several senior finance management positions at medical device and software manufacturer Varian Medical Systems. Mr. Siu also worked three years with Deloitte and left as an Audit Manager, and began his career in public accounting serving over five years with EY. He is a Certified Public Accountant (inactive) in California. Mr. Siu holds a Bachelor of Science degree in Accounting from Brigham Young University in Hawaii and a Master of Business Administration degree from the University of California at Berkeley.Valuation Update With 7 Day Price Move • May 10Investor sentiment improves as stock rises 19%After last week's 19% share price gain to €26.33, the stock trades at a trailing P/E ratio of 56x. Average forward P/E is 17x in the Semiconductor industry in Germany. Total returns to shareholders of 1,754% over the past three years.Valuation Update With 7 Day Price Move • Apr 25Investor sentiment deteriorates as stock falls 21%After last week's 21% share price decline to €21.40, the stock trades at a trailing P/E ratio of 48x. Average forward P/E is 17x in the Semiconductor industry in Germany. Total returns to shareholders of 1,229% over the past three years.Recent Insider Transactions • Apr 11Independent Director recently sold €775k worth of stockOn the 6th of April, Geoffrey Scott sold around 30k shares on-market at roughly €25.83 per share. This transaction amounted to 11% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger sale from another insider worth €3.3m. Insiders have been net sellers, collectively disposing of €17m more than they bought in the last 12 months.Valuation Update With 7 Day Price Move • Apr 06Investor sentiment deteriorates as stock falls 26%After last week's 26% share price decline to €26.43, the stock trades at a trailing P/E ratio of 53.7x. Average forward P/E is 17x in the Semiconductor industry in Germany. Total returns to shareholders of 1,998% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €10.91 per share.Reported Earnings • Mar 31Third quarter 2023 earnings released: EPS: US$0.15 (vs US$0.083 in 3Q 2022)Third quarter 2023 results: EPS: US$0.15 (up from US$0.083 in 3Q 2022). Revenue: US$17.2m (up 13% from 3Q 2022). Net income: US$4.13m (up 84% from 3Q 2022). Profit margin: 24% (up from 15% in 3Q 2022). Revenue is forecast to grow 44% p.a. on average during the next 2 years, compared to a 8.9% growth forecast for the Semiconductor industry in Germany. Over the last 3 years on average, earnings per share has increased by 109% per year but the company’s share price has increased by 192% per year, which means it is tracking significantly ahead of earnings growth.Valuation Update With 7 Day Price Move • Mar 09Investor sentiment improves as stock rises 33%After last week's 33% share price gain to €29.72, the stock trades at a trailing P/E ratio of 75.9x. Average forward P/E is 17x in the Semiconductor industry in Germany. Total returns to shareholders of 1,993% over the past three years.Valuation Update With 7 Day Price Move • Feb 20Investor sentiment improves as stock rises 20%After last week's 20% share price gain to €34.54, the stock trades at a trailing P/E ratio of 78.1x. Average forward P/E is 17x in the Semiconductor industry in Germany. Total returns to shareholders of 1,576% over the past three years.Recent Insider Transactions • Feb 02Insider recently sold €1.2m worth of stockOn the 27th of January, Vernon Rogers sold around 38k shares on-market at roughly €32.60 per share. This transaction amounted to 50% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger sale from another insider worth €1.7m. Insiders have been net sellers, collectively disposing of €7.8m more than they bought in the last 12 months.お知らせ • Jan 28Aehr Test Systems Announces Board ChangesOn January 24, 2023, Mario Rosati retired as a director of Aehr Test Systems. Mr. Rosati's action was voluntary and did not result from any disagreement with the Company or the Company's Board of Directors (the Board").On January 25, 2023 the Board appointed existing director Rhea Posedel to the Corporate Governance andNominating Committee, replacing Mr. Rosati in this position.Valuation Update With 7 Day Price Move • Jan 28Investor sentiment improves as stock rises 27%After last week's 27% share price gain to €32.03, the stock trades at a trailing P/E ratio of 79.4x. Average forward P/E is 17x in the Semiconductor industry in Germany. Total returns to shareholders of 1,595% over the past three years.Recent Insider Transactions • Jan 13Independent Director recently sold €381k worth of stockOn the 10th of January, Geoffrey Scott sold around 15k shares on-market at roughly €25.41 per share. This transaction amounted to 4.6% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger sale from another insider worth €1.7m. Insiders have been net sellers, collectively disposing of €4.3m more than they bought in the last 12 months.Valuation Update With 7 Day Price Move • Jan 12Investor sentiment improved over the past weekAfter last week's 60% share price gain to €25.95, the stock trades at a trailing P/E ratio of 62.9x. Average forward P/E is 15x in the Semiconductor industry in Germany. Total returns to shareholders of 1,492% over the past three years.お知らせ • Jan 06Aehr Test Systems Reiterates Revenue Guidance for the Fiscal Year Ending May 31, 2023Aehr Test Systems reiterated revenue guidance for the fiscal year ending May 31, 2023. For the fiscal year ending May 31, 2023, Aehr is reiterating its previously provided guidance for total revenue to be $60 million to $70 million, with strong profit margins similar to last fiscal year. Aehr also continues to expect bookings to grow faster than revenues in fiscal 2023 as the ramp in demand for silicon carbide in electric vehicles increases exponentially throughout the decade.Reported Earnings • Jan 06Second quarter 2023 earnings released: EPS: US$0.14 (vs US$0.027 in 2Q 2022)Second quarter 2023 results: EPS: US$0.14 (up from US$0.027 in 2Q 2022). Revenue: US$14.8m (up 54% from 2Q 2022). Net income: US$3.73m (up 420% from 2Q 2022). Profit margin: 25% (up from 7.5% in 2Q 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 38% p.a. on average during the next 3 years, compared to a 8.6% growth forecast for the Semiconductor industry in Germany. Over the last 3 years on average, earnings per share has increased by 106% per year whereas the company’s share price has increased by 105% per year.お知らせ • Dec 23Aehr Test Systems to Report Q2, 2023 Results on Jan 05, 2023Aehr Test Systems announced that they will report Q2, 2023 results at 4:00 PM, US Eastern Standard Time on Jan 05, 2023Recent Insider Transactions • Nov 18President recently sold €1.7m worth of stockOn the 15th of November, Gayn Erickson sold around 70k shares on-market at roughly €24.93 per share. This transaction amounted to 13% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was Gayn's only on-market trade for the last 12 months.Valuation Update With 7 Day Price Move • Nov 12Investor sentiment improved over the past weekAfter last week's 23% share price gain to €23.61, the stock trades at a forward P/E ratio of 52x. Average forward P/E is 15x in the Semiconductor industry in Germany. Total returns to shareholders of 1,105% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €13.95 per share.Recent Insider Transactions • Nov 02Vice President of Engineering recently sold €463k worth of stockOn the 28th of October, Donald Richmond sold around 22k shares on-market at roughly €21.12 per share. This transaction amounted to 12% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of €5.2m more than they bought in the last 12 months.Valuation Update With 7 Day Price Move • Oct 21Investor sentiment improved over the past weekAfter last week's 25% share price gain to €18.30, the stock trades at a forward P/E ratio of 41x. Average forward P/E is 13x in the Semiconductor industry in Germany. Total returns to shareholders of 1,073% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €15.38 per share.Reported Earnings • Oct 08First quarter 2023 earnings released: EPS: US$0.022 (vs US$0.029 in 1Q 2022)First quarter 2023 results: EPS: US$0.022 (down from US$0.029 in 1Q 2022). Revenue: US$10.7m (up 89% from 1Q 2022). Net income: US$589.0k (down 15% from 1Q 2022). Profit margin: 5.5% (down from 12% in 1Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 35% p.a. on average during the next 2 years, compared to a 8.6% growth forecast for the Semiconductor industry in Germany. Over the last 3 years on average, earnings per share has increased by 98% per year but the company’s share price has increased by 124% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Oct 07+ 1 more updateAehr Test Systems Provides Revenue Guidance for the Fiscal Year Ending May 31, 2023For the fiscal year ending May 31, 2023, Aehr Test Systems is reiterating its previously provided guidance for total revenue to be at least $60 million to $70 million, with strong profit margins similar to last fiscal year. Aehr also continues to expect bookings to grow faster than revenues in fiscal 2023 as the ramp in demand for silicon carbide in electric vehicles increases exponentially throughout the decade.Valuation Update With 7 Day Price Move • Sep 28Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to €13.46, the stock trades at a trailing P/E ratio of 39.6x. Average forward P/E is 12x in the Semiconductor industry in Germany. Total returns to shareholders of 768% over the past three years.お知らせ • Sep 24Aehr Test Systems, Annual General Meeting, Oct 18, 2022Aehr Test Systems, Annual General Meeting, Oct 18, 2022, at 16:00 Pacific Daylight. Location: 400 Kato Terrace, Fremont, California 94539 california United States Agenda: To elect seven directors of the company to hold office until the next annual meeting or the election of their successors; to approve an amendment to the company's amended and restated 2006 employee stock purchase plan (the "espp") to increase the number of shares reserved for issuance thereunder by an additional 350,000 shares of common stock of the company ("common stock"); to ratify the selection of BPM LLP as the company’s independent registered public accounting firm for the fiscal year ending May 31, 2023; to approve, on an advisory (non-binding) basis, the compensation of the company’s named executive officers; and to transact such other business as may properly come before the annual meeting or any postponements or adjournments thereof.お知らせ • Sep 21Aehr Test Systems to Report Q1, 2023 Results on Oct 06, 2022Aehr Test Systems announced that they will report Q1, 2023 results After-Market on Oct 06, 2022Valuation Update With 7 Day Price Move • Sep 02Investor sentiment deteriorated over the past weekAfter last week's 25% share price decline to €13.39, the stock trades at a trailing P/E ratio of 39.1x. Average forward P/E is 13x in the Semiconductor industry in Germany. Total returns to shareholders of 981% over the past three years.Reported Earnings • Aug 28Full year 2022 earnings released: EPS: US$0.36 (vs US$0.086 loss in FY 2021)Full year 2022 results: EPS: US$0.36 (up from US$0.086 loss in FY 2021). Revenue: US$50.8m (up 206% from FY 2021). Net income: US$9.45m (up US$11.5m from FY 2021). Profit margin: 19% (up from net loss in FY 2021). Over the next year, revenue is forecast to grow 22%, compared to a 12% growth forecast for the Semiconductor industry in Germany. Over the last 3 years on average, earnings per share has increased by 86% per year but the company’s share price has increased by 148% per year, which means it is tracking significantly ahead of earnings growth.Valuation Update With 7 Day Price Move • Aug 09Investor sentiment improved over the past weekAfter last week's 27% share price gain to €15.04, the stock trades at a trailing P/E ratio of 42.6x. Average forward P/E is 16x in the Semiconductor industry in Germany. Total returns to shareholders of 1,200% over the past three years.Recent Insider Transactions • Aug 05Independent Director recently sold €123k worth of stockOn the 2nd of August, Howard Slayen sold around 10k shares on-market at roughly €12.26 per share. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of €13m more than they bought in the last 12 months.Valuation Update With 7 Day Price Move • Jul 26Investor sentiment improved over the past weekAfter last week's 21% share price gain to €10.45, the stock trades at a trailing P/E ratio of 30.7x. Average forward P/E is 16x in the Semiconductor industry in Germany. Total returns to shareholders of 741% over the past three years.Reported Earnings • Jul 21Full year 2022 earnings released: EPS: US$0.36 (vs US$0.086 loss in FY 2021)Full year 2022 results: EPS: US$0.36 (up from US$0.086 loss in FY 2021). Revenue: US$50.8m (up 206% from FY 2021). Net income: US$9.45m (up US$11.5m from FY 2021). Profit margin: 19% (up from net loss in FY 2021). Over the next year, revenue is forecast to grow 22%, compared to a 14% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 86% per year but the company’s share price has increased by 96% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Jul 20Aehr Test Systems Provides Earnings Guidance for the Fiscal Year 2023Aehr Test Systems provided earnings guidance for the fiscal year 2023. For the year, the company expected total revenue to be at least $60 million to $70 million, with strong profit margins similar to last fiscal year. Aehr also expects bookings to grow faster than revenues in fiscal 2023 as the ramp in demand for silicon carbide in electric vehicles increases exponentially throughout the decade.お知らせ • Jul 13Aehr Test Systems to Report Fiscal Year 2022 Results on Jul 19, 2022Aehr Test Systems announced that they will report fiscal year 2022 results at 4:00 PM, US Eastern Standard Time on Jul 19, 2022Valuation Update With 7 Day Price Move • Jun 03Investor sentiment improved over the past weekAfter last week's 23% share price gain to €8.75, the stock trades at a trailing P/E ratio of 60.9x. Average forward P/E is 17x in the Semiconductor industry in Germany. Total returns to shareholders of 509% over the past three years.Valuation Update With 7 Day Price Move • May 18Investor sentiment improved over the past weekAfter last week's 15% share price gain to €7.87, the stock trades at a trailing P/E ratio of 53.6x. Average forward P/E is 16x in the Semiconductor industry in Germany. Total returns to shareholders of 470% over the past three years.お知らせ • Apr 03Aehr Test Systems Appoints Adil Engineer as the Chief Operating Officer, Effective April 6, 2022Aehr Test Systems appointed Adil Engineer as the Company's Chief Operating Officer, effective April 6, 2022. David Fucci, Interim Vice-President of Operations with the Company, will remain through the fiscal year end May 31, 2022 to assist in the transition. Mr. Engineer, age 45, has built a career in operations and supply chain and has been in the semiconductor and medical equipment field for over 20 years. He started his career with semiconductor equipment company KLA-Tencor where he spent 11 years, and also worked at Coherent and Kateeva in positions of increasing responsibility in manufacturing, manufacturing engineering, new product introduction, and supply chain. Most recently he was the Head of Operations at Tecan, a Swiss company manufacturing medical test and diagnostic tools, devices, and solutions, where he oversaw operations for Tecan’s primary site in the US for manufacturing, located in San Jose. Adil has a Bachelor of Science in Chemical Engineering from TKIET, Shivaji University, India, and a Graduate Certificate in Management Science and Engineering from Leland Stanford Jr. University, Stanford, California. Mr. Engineer does not have a family relationship with any member of the Board or any executive officer of the Company, and Mr. Engineer has not been a participant or had an interest in any transaction with the Company that is reportable under Item 404(a) of Regulation S-K.Reported Earnings • Apr 02Third quarter 2022 earnings released: EPS: US$0.083 (vs US$0.031 loss in 3Q 2021)Third quarter 2022 results: EPS: US$0.083 (up from US$0.031 loss in 3Q 2021). Revenue: US$15.3m (up 190% from 3Q 2021). Net income: US$2.24m (up US$2.98m from 3Q 2021). Profit margin: 15% (up from net loss in 3Q 2021). Over the next year, revenue is forecast to grow 72%, compared to a 16% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 62% per year but the company’s share price has increased by 79% per year, which means it is tracking significantly ahead of earnings growth.株主還元AYBDE SemiconductorDE 市場7D-11.6%4.9%2.0%1Y854.3%105.1%-0.1%株主還元を見る業界別リターン: AYB過去 1 年間で105.1 % の収益を上げたGerman Semiconductor業界を上回りました。リターン対市場: AYB過去 1 年間で-0.1 % の収益を上げたGerman市場を上回りました。価格変動Is AYB's price volatile compared to industry and market?AYB volatilityAYB Average Weekly Movement18.9%Semiconductor Industry Average Movement9.2%Market Average Movement6.2%10% most volatile stocks in DE Market13.3%10% least volatile stocks in DE Market2.7%安定した株価: AYBの株価は、 German市場と比較して過去 3 か月間で変動しています。時間の経過による変動: AYBの weekly volatility ( 19% ) は過去 1 年間安定していますが、依然としてGermanの株式の 75% よりも高くなっています。会社概要設立従業員CEO（最高経営責任者ウェブサイト1977136Gayn Ericksonwww.aehr.comAehr Test Systems, Inc.は、ウェハレベル、シングルドダイ、パッケージ・パーツ・フォーム、およびインストール・システムにおけるテスト、バーンイン、半導体デバイスのテスト・ソリューションを世界中に提供しています。同社の製品ポートフォリオには、炭化ケイ素系およびその他のパワー半導体、携帯電話やタブレット、その他のコンピューティングデバイスに使用される2Dおよび3Dセンサー、メモリー半導体、プロセッサー、マイクロコントローラー、システムオンチップ、フォトニクスおよび集積光学デバイスなど、さまざまなデバイスのテスト、バーンイン、安定化が可能なフルウエハーコンタクトおよびシングルドダイ/モジュールテストおよびバーンインシステムであるFOX-XPおよびFOX-NPシステムが含まれる。また、ロジック、メモリ、フォトニックデバイス向けの低コストな枚葉式小型テストソリューションであるFOX-CPシステム、および、集積回路メーカーがFOX-Pシステム上でフルウェーハのテスト、バーンイン、安定化を行うことを可能にする、300mmまでのウェーハをテスト可能なフルウェーハコンタクタであるFOX WaferPak Contactorを提供している。さらに、FOX DiePak Carrierを提供し、シングル化されたベアダイとモジュールのテスト、バーンイン、安定化を可能にする。同社は1977年に設立され、カリフォルニア州フリーモントに本社を置いている。もっと見るAehr Test Systems, Inc. 基礎のまとめAehr Test Systems の収益と売上を時価総額と比較するとどうか。AYB 基礎統計学時価総額€2.19b収益（TTM）-€9.82m売上高(TTM)€38.91m57.2xP/Sレシオ-226.9xPER（株価収益率AYB は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計AYB 損益計算書（TTM）収益US$45.26m売上原価US$31.35m売上総利益US$13.90mその他の費用US$25.32m収益-US$11.42m直近の収益報告Feb 27, 2026次回決算日該当なし一株当たり利益（EPS）-0.36グロス・マージン30.72%純利益率-25.23%有利子負債／自己資本比率0%AYB の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/20 14:10終値2026/05/20 00:00収益2026/02/27年間収益2025/05/30データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Aehr Test Systems, Inc. 4 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。5 アナリスト機関Christian SchwabCraig-Hallum Capital Group LLCEgor TolmachevFreedom BrokerDanial YermakhanFreedom Broker2 その他のアナリストを表示
Board Change • 15hInsufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. Independent Director Fariba Danesh was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
お知らせ • Apr 09Aehr Test Systems, Inc. has filed a Follow-on Equity Offering in the amount of $60 million.Aehr Test Systems, Inc. has filed a Follow-on Equity Offering in the amount of $60 million. Security Name: Common Stock Security Type: Common Stock Transaction Features: At the Market Offering
お知らせ • Mar 30Aehr Test Systems, Inc. to Report Q3, 2026 Results on Apr 07, 2026Aehr Test Systems, Inc. announced that they will report Q3, 2026 results After-Market on Apr 07, 2026
お知らせ • Jan 09Aehr Test Systems, Inc. Reinstates Earnings Guidance for the Second Half of Fiscal 2026Aehr Test Systems, Inc. reinstated earnings guidance for the second half of fiscal 2026. For the period, which began November 29, 2025 and ends this May 29, 2026, Aehr expects revenue between $25 million and $30 million.
お知らせ • Dec 30Aehr Test Systems, Inc. to Report Q2, 2026 Results on Jan 08, 2026Aehr Test Systems, Inc. announced that they will report Q2, 2026 results After-Market on Jan 08, 2026
お知らせ • Sep 29Aehr Test Systems, Inc. to Report Q1, 2026 Results on Oct 06, 2025Aehr Test Systems, Inc. announced that they will report Q1, 2026 results at 4:00 PM, US Eastern Standard Time on Oct 06, 2025
Board Change • 15hInsufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. Independent Director Fariba Danesh was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
お知らせ • Apr 09Aehr Test Systems, Inc. has filed a Follow-on Equity Offering in the amount of $60 million.Aehr Test Systems, Inc. has filed a Follow-on Equity Offering in the amount of $60 million. Security Name: Common Stock Security Type: Common Stock Transaction Features: At the Market Offering
お知らせ • Mar 30Aehr Test Systems, Inc. to Report Q3, 2026 Results on Apr 07, 2026Aehr Test Systems, Inc. announced that they will report Q3, 2026 results After-Market on Apr 07, 2026
お知らせ • Jan 09Aehr Test Systems, Inc. Reinstates Earnings Guidance for the Second Half of Fiscal 2026Aehr Test Systems, Inc. reinstated earnings guidance for the second half of fiscal 2026. For the period, which began November 29, 2025 and ends this May 29, 2026, Aehr expects revenue between $25 million and $30 million.
お知らせ • Dec 30Aehr Test Systems, Inc. to Report Q2, 2026 Results on Jan 08, 2026Aehr Test Systems, Inc. announced that they will report Q2, 2026 results After-Market on Jan 08, 2026
お知らせ • Sep 29Aehr Test Systems, Inc. to Report Q1, 2026 Results on Oct 06, 2025Aehr Test Systems, Inc. announced that they will report Q1, 2026 results at 4:00 PM, US Eastern Standard Time on Oct 06, 2025
お知らせ • Sep 11Aehr Test Systems, Inc., Annual General Meeting, Oct 20, 2025Aehr Test Systems, Inc., Annual General Meeting, Oct 20, 2025. Location: 400kato terrace, california 94539, fremont United States
お知らせ • Jun 30Aehr Test Systems, Inc. to Report Q4, 2025 Results on Jul 08, 2025Aehr Test Systems, Inc. announced that they will report Q4, 2025 results After-Market on Jul 08, 2025
お知らせ • Mar 28Aehr Test Systems, Inc. to Report Q3, 2025 Results on Apr 08, 2025Aehr Test Systems, Inc. announced that they will report Q3, 2025 results at 4:00 PM, US Eastern Standard Time on Apr 08, 2025
お知らせ • Jan 14Aehr Test Systems Reiterates Earnings Guidance for Fiscal Year Ending May 30, 2025For the fiscal year ending May 30, 2025, Aehr Test Systems, Inc. reiterated its previously provided guidance for total revenue of at least $70 million.
お知らせ • Jan 01Aehr Test Systems, Inc. to Report Q2, 2025 Results on Jan 13, 2025Aehr Test Systems, Inc. announced that they will report Q2, 2025 results at 4:00 PM, US Eastern Standard Time on Jan 13, 2025
Board Change • Dec 30Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. Independent Director Fariba Danesh was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
お知らせ • Dec 06Gewirtz & Grossman LLC Notifies Class Action Lawsuit Filed Against Aehr Test Systems, IncGewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Aehr Test Systems, Inc. and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Aehr securities between January 9, 2024 and March 24, 2024, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site. The Complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that: (1) contrary to prior representations to investors, Aehr was continuing to experience substantial delays in customer orders; (2) the foregoing issue was likely to have a material negative impact on the Company's revenue growth; (3) accordingly, the Company's business and/or financial prospects were overstated; and (4) as a result, the Company's public statements were materially false and misleading at all relevant times. A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm’s site: bgandg.com/AEHR. or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 332-239-2660. If you suffered a loss in Aehr you have until February 3, 2025, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff. We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys’ fees, usually a percentage of the total recovery, only if we are successful. Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide. Attorney advertising. Prior results do not guarantee similar outcomes.
Valuation Update With 7 Day Price Move • Nov 01Investor sentiment deteriorates as stock falls 21%After last week's 21% share price decline to €12.74, the stock trades at a trailing P/E ratio of 14.3x. Average forward P/E is 13x in the Semiconductor industry in Germany. Total loss to shareholders of 44% over the past three years.
お知らせ • Oct 16Aehr Test Systems, Inc. has filed a Follow-on Equity Offering in the amount of $40 million.Aehr Test Systems, Inc. has filed a Follow-on Equity Offering in the amount of $40 million. Security Name: Common Stock Security Type: Common Stock Transaction Features: At the Market Offering
Reported Earnings • Oct 11First quarter 2025 earnings released: EPS: US$0.023 (vs US$0.16 in 1Q 2024)First quarter 2025 results: EPS: US$0.023 (down from US$0.16 in 1Q 2024). Revenue: US$13.1m (down 36% from 1Q 2024). Net income: US$660.0k (down 86% from 1Q 2024). Profit margin: 5.0% (down from 23% in 1Q 2024). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 27% p.a. on average during the next 3 years, compared to a 8.0% growth forecast for the Semiconductor industry in Germany. Over the last 3 years on average, earnings per share has increased by 66% per year but the company’s share price has fallen by 12% per year, which means it is significantly lagging earnings.
お知らせ • Oct 11Aehr Test Systems, Inc. Reaffirms Earnings Guidance for the Fiscal Year Ending May 30, 2025Aehr Test Systems, Inc. reaffirms earnings guidance for the fiscal year ending May 30, 2025. For the fiscal year ending May 30, 2025, Aehr is reiterating its previously provided guidance for total revenue of at least $70 million and net profit before taxes of at least 10% of revenue.
お知らせ • Oct 02Aehr Test Systems, Inc. to Report Q1, 2025 Results on Oct 10, 2024Aehr Test Systems, Inc. announced that they will report Q1, 2025 results After-Market on Oct 10, 2024
お知らせ • Sep 12Aehr Test Systems, Inc., Annual General Meeting, Oct 21, 2024Aehr Test Systems, Inc., Annual General Meeting, Oct 21, 2024. Location: 400 kato terrace, california 94539, fremont United States
Valuation Update With 7 Day Price Move • Aug 30Investor sentiment improves as stock rises 15%After last week's 15% share price gain to €13.73, the stock trades at a trailing P/E ratio of 13.6x. Average forward P/E is 14x in the Semiconductor industry in Germany. Total returns to shareholders of 97% over the past three years.
Valuation Update With 7 Day Price Move • Aug 06Investor sentiment deteriorates as stock falls 21%After last week's 21% share price decline to €12.93, the stock trades at a trailing P/E ratio of 13.4x. Average forward P/E is 14x in the Semiconductor industry in Germany. Total returns to shareholders of 165% over the past three years.
Recent Insider Transactions • Aug 01Independent Director recently sold €172k worth of stockOn the 30th of July, Fariba Danesh sold around 10k shares on-market at roughly €17.21 per share. This transaction amounted to 70% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of €887k more than they bought in the last 12 months.
お知らせ • Jul 17+ 1 more updateAehr Test Systems (NasdaqCM:AEHR) agreed to acquire Incal Technology, Inc for $23.1.Aehr Test Systems (NasdaqCM:AEHR) agreed to acquire Incal Technology, Inc for $23.1 on July 15, 2024. A cash consideration of $14 million will be paid by Aehr Test Systems. The consideration consists of 0.55 million common equity of Aehr Test Systems to be issued for common equity of Incal Technology, Inc. The transaction has been approved by the board of directors of both companies and the Acquisition is expected to close within 60 days, subject to customary closing conditions. The transaction is subject to certain post-closing adjustments with respect to working capital. Latham & Watkins LLP acted as legal advisor for Aehr Test Systems.
Valuation Update With 7 Day Price Move • Jul 12Investor sentiment improves as stock rises 39%After last week's 39% share price gain to €13.92, the stock trades at a trailing P/E ratio of 28.4x. Average forward P/E is 17x in the Semiconductor industry in Germany. Total returns to shareholders of 338% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €8.58 per share.
Buy Or Sell Opportunity • Jul 09Now 33% overvalued after recent price riseOver the last 90 days, the stock has risen 3.9% to €11.63. The fair value is estimated to be €8.72, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 48% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to decline by 6.6% in a year. Earnings are forecast to decline by 22% in the next year.
お知らせ • Jul 04Aehr Test Systems to Report Q4, 2024 Results on Jul 16, 2024Aehr Test Systems announced that they will report Q4, 2024 results After-Market on Jul 16, 2024
Buy Or Sell Opportunity • Jul 01Now 20% overvaluedOver the last 90 days, the stock has fallen 6.0% to €10.36. The fair value is estimated to be €8.61, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 48% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to decline by 6.6% in a year. Earnings are forecast to decline by 22% in the next year.
Buy Or Sell Opportunity • Jun 27Now 21% overvaluedOver the last 90 days, the stock has fallen 12% to €9.95. The fair value is estimated to be €8.25, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 48% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to decline by 6.6% in a year. Earnings are forecast to decline by 22% in the next year.
Valuation Update With 7 Day Price Move • Jun 26Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to €9.45, the stock trades at a trailing P/E ratio of 19.7x. Average forward P/E is 14x in the Semiconductor industry in Germany. Total returns to shareholders of 318% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €8.31 per share.
Valuation Update With 7 Day Price Move • Jun 06Investor sentiment improves as stock rises 18%After last week's 18% share price gain to €11.55, the stock trades at a trailing P/E ratio of 25.1x. Average forward P/E is 15x in the Semiconductor industry in Germany. Total returns to shareholders of 439% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €7.77 per share.
Board Change • Jun 02Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. Independent Director Fariba Danesh was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Buy Or Sell Opportunity • Jun 01Now 27% overvaluedOver the last 90 days, the stock has fallen 30% to €10.50. The fair value is estimated to be €8.26, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 48% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to decline by 6.6% in a year. Earnings are forecast to decline by 22% in the next year.
Buy Or Sell Opportunity • May 11Now 22% overvaluedOver the last 90 days, the stock has fallen 33% to €10.46. The fair value is estimated to be €8.60, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 48% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to decline by 6.6% in a year. Earnings are forecast to decline by 22% in the next year.
New Risk • Apr 12New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 14% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Earnings are forecast to decline by an average of 14% per year for the foreseeable future. High level of non-cash earnings (34% accrual ratio). Minor Risks Shareholders have been diluted in the past year (4.2% increase in shares outstanding). Significant insider selling over the past 3 months (€140k sold).
Buy Or Sell Opportunity • Apr 10Now 25% overvaluedOver the last 90 days, the stock has fallen 31% to €11.20. The fair value is estimated to be €8.96, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 48% over the last 3 years. Meanwhile, the company has become profitable.
Reported Earnings • Apr 10Third quarter 2024 earnings released: US$0.051 loss per share (vs US$0.15 profit in 3Q 2023)Third quarter 2024 results: US$0.051 loss per share (down from US$0.15 profit in 3Q 2023). Revenue: US$7.56m (down 56% from 3Q 2023). Net loss: US$1.47m (down 136% from profit in 3Q 2023). Revenue is expected to decline by 5.7% p.a. on average during the next 2 years, while revenues in the Semiconductor industry in Germany are expected to grow by 8.3%. Over the last 3 years on average, earnings per share has increased by 83% per year whereas the company’s share price has increased by 79% per year.
お知らせ • Apr 10Aehr Test Systems Provides Earnings Guidance for the Fiscal Year Ending May 31, 2024Aehr Test Systems provides earnings guidance for the fiscal year ending May 31, 2024. For the period, the company reiterating its previously provided guidance for total revenue of greater than $65 million and GAAP net income of approximately $11 million or more, or $0.38 per diluted share.
Valuation Update With 7 Day Price Move • Mar 30Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to €11.33, the stock trades at a trailing P/E ratio of 17x. Average forward P/E is 14x in the Semiconductor industry in Germany. Total returns to shareholders of 434% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €6.68 per share.
お知らせ • Mar 26Aehr Test Systems to Report Q3, 2024 Results on Apr 09, 2024Aehr Test Systems announced that they will report Q3, 2024 results on Apr 09, 2024
Valuation Update With 7 Day Price Move • Mar 16Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to €13.03, the stock trades at a trailing P/E ratio of 19.5x. Average forward P/E is 16x in the Semiconductor industry in Germany. Total returns to shareholders of 515% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €6.71 per share.
Valuation Update With 7 Day Price Move • Feb 09Investor sentiment improves as stock rises 17%After last week's 17% share price gain to €15.96, the stock trades at a trailing P/E ratio of 23.1x. Average forward P/E is 19x in the Semiconductor industry in Germany. Total returns to shareholders of 571% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €7.08 per share.
New Risk • Jan 22New minor risk - Insider sellingThere has been significant insider selling in the company's shares over the past 3 months. Total value of shares sold: €147k This is considered a minor risk. There are several reasons why an insider may be selling, including to cover a tax obligation or pay for some other expense. However, we generally consider it a negative if insiders have been selling, especially if they do so below the current price. It implies that they considered a lower price to be reasonable. This is a weak signal, but if there is a pattern of unexplained selling, it can be a sign the insider believes the company's stock is overpriced. Note: We only include open market transactions and private dispositions of directly owned stock by individuals, not by corporations or trusts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). High level of non-cash earnings (52% accrual ratio). Minor Risks Shareholders have been diluted in the past year (3.9% increase in shares outstanding). Significant insider selling over the past 3 months (€147k sold).
Recent Insider Transactions • Jan 22President recently sold €78k worth of stockOn the 18th of January, Gayn Erickson sold around 5k shares on-market at roughly €16.01 per share. This transaction amounted to 1.6% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Gayn has been a net seller over the last 12 months, reducing personal holdings by €5.7m.
Reported Earnings • Jan 10Second quarter 2024 earnings released: EPS: US$0.21 (vs US$0.14 in 2Q 2023)Second quarter 2024 results: EPS: US$0.21 (up from US$0.14 in 2Q 2023). Revenue: US$21.4m (up 45% from 2Q 2023). Net income: US$6.09m (up 64% from 2Q 2023). Profit margin: 28% (up from 25% in 2Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 214% p.a. on average during the next 2 years, compared to a 8.0% growth forecast for the Semiconductor industry in Germany. Over the last 3 years on average, earnings per share has increased by 99% per year but the company’s share price has increased by 122% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Jan 10Aehr Test Systems Provides Earnings Guidance for the Fiscal Year Ending May 31, 2024Aehr Test Systems provided earnings guidance For the fiscal year ending May 31, 2024. For the year, the company is revising its expected full year total revenue to be between $75 million and $85 million, representing growth of 15% to 30% year over year, and GAAP net income of between 20% and 25% of revenue.
Valuation Update With 7 Day Price Move • Nov 03Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to €23.35, the stock trades at a trailing P/E ratio of 38.2x. Average forward P/E is 15x in the Semiconductor industry in Germany. Total returns to shareholders of 2,271% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €9.44 per share.
お知らせ • Oct 21Aehr Test Systems Announces Resignation of Rhea J. Posedel from Corporate Governance and Nominating CommitteeAehr Test Systems announced that Rhea J. Posedel resigned from the Corporate Governance and Nominating Committee of AEHR Test Systems Inc. (the “Company”) effective October 19, 2023. Although Mr. Posedel will continue to stand for election at the Company’s Annual Meeting of Shareholders (to be held on October 23, 2023, at 4:00 p.m.), he will not in the future be nominated or appointed to any of the Company’s committees made up of independent directors including the Corporate Governance and Nominating Committee, Audit Committee, and the Compensation Committee. The new chair of the Corporate Governance and Nominating Committee will be appointed at the upcoming meeting of the Board of Directors (the “Board”) on October 23, 2023.
Valuation Update With 7 Day Price Move • Oct 19Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to €30.76, the stock trades at a trailing P/E ratio of 49x. Average forward P/E is 14x in the Semiconductor industry in Germany. Total returns to shareholders of 2,775% over the past three years.
Reported Earnings • Oct 06First quarter 2024 earnings released: EPS: US$0.16 (vs US$0.022 in 1Q 2023)First quarter 2024 results: EPS: US$0.16 (up from US$0.022 in 1Q 2023). Revenue: US$20.6m (up 93% from 1Q 2023). Net income: US$4.67m (up US$4.09m from 1Q 2023). Profit margin: 23% (up from 5.5% in 1Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 39% p.a. on average during the next 3 years, compared to a 8.0% growth forecast for the Semiconductor industry in Germany. Over the last 3 years on average, earnings per share has increased by 106% per year but the company’s share price has increased by 236% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Oct 06Aehr Test Systems Reiterates Earnings Guidance for the Fiscal Year Ending May 31, 2024Aehr Test Systems reiterated earnings guidance for the fiscal year ending May 31, 2024. For the year, the company expects total revenue to be at least $100 million, representing growth of over 50% year over year, and GAAP net income of at least $28 million, representing earnings growth of greater than 90% year over year.
お知らせ • Sep 27Aehr Test Systems to Report Q1, 2024 Results on Oct 05, 2023Aehr Test Systems announced that they will report Q1, 2024 results at 5:00 PM, US Eastern Standard Time on Oct 05, 2023
お知らせ • Sep 14Aehr Test Systems, Annual General Meeting, Oct 23, 2023Aehr Test Systems, Annual General Meeting, Oct 23, 2023, at 16:00 Pacific Daylight. Location: corporate headquarters located at 400 Kato Terrace Fremont California United States Agenda: to consider and elect six directors of the company to hold office until the next annual meeting or the election of their successors; to consider and ratify the selection of bpm llp as the company’s independent registered public accounting firm for the fiscal year ending may 31, 2024; to consider and approve, on an advisory (non-binding) basis, the compensation of the company’s named executive officers; to transact such other business as may properly come before the annual meeting or any postponements or adjournments thereof.
Reported Earnings • Aug 30Full year 2023 earnings released: EPS: US$0.52 (vs US$0.36 in FY 2022)Full year 2023 results: EPS: US$0.52 (up from US$0.36 in FY 2022). Revenue: US$65.0m (up 28% from FY 2022). Net income: US$14.6m (up 54% from FY 2022). Profit margin: 22% (up from 19% in FY 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 38% p.a. on average during the next 3 years, compared to a 7.9% growth forecast for the Semiconductor industry in Germany. Over the last 3 years on average, earnings per share has increased by 110% per year but the company’s share price has increased by 209% per year, which means it is tracking significantly ahead of earnings growth.
Valuation Update With 7 Day Price Move • Aug 18Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to €37.53, the stock trades at a trailing P/E ratio of 77.7x. Average forward P/E is 15x in the Semiconductor industry in Germany. Total returns to shareholders of 2,260% over the past three years.
Recent Insider Transactions • Jul 21President recently sold €5.7m worth of stockOn the 17th of July, Gayn Erickson sold around 124k shares on-market at roughly €45.65 per share. This transaction amounted to 29% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Gayn has been a net seller over the last 12 months, reducing personal holdings by €7.4m.
Reported Earnings • Jul 14Full year 2023 earnings released: EPS: US$0.52 (vs US$0.36 in FY 2022)Full year 2023 results: EPS: US$0.52 (up from US$0.36 in FY 2022). Revenue: US$65.0m (up 28% from FY 2022). Net income: US$14.6m (up 54% from FY 2022). Profit margin: 22% (up from 19% in FY 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 38% p.a. on average during the next 3 years, compared to a 8.3% growth forecast for the Semiconductor industry in Germany. Over the last 3 years on average, earnings per share has increased by 110% per year but the company’s share price has increased by 194% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Jul 14Aehr Test Systems Provides Earnings Guidance for the Year 2024For the fiscal year ending May 31, 2024, Aehr Test Systems expects total revenue to be at least $100 million, representing growth of over 50% year over year, and GAAP net income of at least $28 million, representing earnings growth of greater than 90% year over year.
お知らせ • Jul 06Aehr Test Systems to Report Q4, 2023 Results on Jul 13, 2023Aehr Test Systems announced that they will report Q4, 2023 results at 4:00 PM, US Eastern Standard Time on Jul 13, 2023
お知らせ • Jun 01Aehr Test Systems Appoints Chris Siu, as Chief Financial Officer Effective June 1, 2023Aehr Test Systems announced the appointment of Chris Siu as the Company’s Chief Financial Officer, Executive Vice President of Finance, and Secretary effective June 1, 2023. He will succeed Ken Spink, who previously announced his planned retirement after 15 years with the Company. Mr. Spink will stay on through the completion of Aehr’s fiscal 2023 year that ends May 31, 2023 and annual 10-K filing to ensure an orderly transition. Mr. Siu brings more than 27 years of finance and accounting experience in the semiconductor, medical equipment, and public accounting industries. Before joining Aehr Test Systems, he most recently served four years in senior finance executive positions at publicly traded Ultra Clean Technologies, a global leading developer and supplier of critical subsystems, components and parts, and ultra-high purity clean and analytical services primarily for the semiconductor and semiconductor equipment industry, including Senior Vice President of Finance, Corporate Treasurer, and Chief Accounting Officer. Prior to Ultra Clean Technologies, Mr. Siu held senior management roles at PDF Solutions and also GlobalFoundries, a multinational semiconductor manufacturing company, where he served for eight years including leading all global accounting functions as Corporate Controller for four years. He was also Chief Accounting Officer and Director of Finance at semiconductor company Trident Microsystems and served in several senior finance management positions at medical device and software manufacturer Varian Medical Systems. Mr. Siu also worked three years with Deloitte and left as an Audit Manager, and began his career in public accounting serving over five years with EY. He is a Certified Public Accountant (inactive) in California. Mr. Siu holds a Bachelor of Science degree in Accounting from Brigham Young University in Hawaii and a Master of Business Administration degree from the University of California at Berkeley.
Valuation Update With 7 Day Price Move • May 10Investor sentiment improves as stock rises 19%After last week's 19% share price gain to €26.33, the stock trades at a trailing P/E ratio of 56x. Average forward P/E is 17x in the Semiconductor industry in Germany. Total returns to shareholders of 1,754% over the past three years.
Valuation Update With 7 Day Price Move • Apr 25Investor sentiment deteriorates as stock falls 21%After last week's 21% share price decline to €21.40, the stock trades at a trailing P/E ratio of 48x. Average forward P/E is 17x in the Semiconductor industry in Germany. Total returns to shareholders of 1,229% over the past three years.
Recent Insider Transactions • Apr 11Independent Director recently sold €775k worth of stockOn the 6th of April, Geoffrey Scott sold around 30k shares on-market at roughly €25.83 per share. This transaction amounted to 11% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger sale from another insider worth €3.3m. Insiders have been net sellers, collectively disposing of €17m more than they bought in the last 12 months.
Valuation Update With 7 Day Price Move • Apr 06Investor sentiment deteriorates as stock falls 26%After last week's 26% share price decline to €26.43, the stock trades at a trailing P/E ratio of 53.7x. Average forward P/E is 17x in the Semiconductor industry in Germany. Total returns to shareholders of 1,998% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €10.91 per share.
Reported Earnings • Mar 31Third quarter 2023 earnings released: EPS: US$0.15 (vs US$0.083 in 3Q 2022)Third quarter 2023 results: EPS: US$0.15 (up from US$0.083 in 3Q 2022). Revenue: US$17.2m (up 13% from 3Q 2022). Net income: US$4.13m (up 84% from 3Q 2022). Profit margin: 24% (up from 15% in 3Q 2022). Revenue is forecast to grow 44% p.a. on average during the next 2 years, compared to a 8.9% growth forecast for the Semiconductor industry in Germany. Over the last 3 years on average, earnings per share has increased by 109% per year but the company’s share price has increased by 192% per year, which means it is tracking significantly ahead of earnings growth.
Valuation Update With 7 Day Price Move • Mar 09Investor sentiment improves as stock rises 33%After last week's 33% share price gain to €29.72, the stock trades at a trailing P/E ratio of 75.9x. Average forward P/E is 17x in the Semiconductor industry in Germany. Total returns to shareholders of 1,993% over the past three years.
Valuation Update With 7 Day Price Move • Feb 20Investor sentiment improves as stock rises 20%After last week's 20% share price gain to €34.54, the stock trades at a trailing P/E ratio of 78.1x. Average forward P/E is 17x in the Semiconductor industry in Germany. Total returns to shareholders of 1,576% over the past three years.
Recent Insider Transactions • Feb 02Insider recently sold €1.2m worth of stockOn the 27th of January, Vernon Rogers sold around 38k shares on-market at roughly €32.60 per share. This transaction amounted to 50% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger sale from another insider worth €1.7m. Insiders have been net sellers, collectively disposing of €7.8m more than they bought in the last 12 months.
お知らせ • Jan 28Aehr Test Systems Announces Board ChangesOn January 24, 2023, Mario Rosati retired as a director of Aehr Test Systems. Mr. Rosati's action was voluntary and did not result from any disagreement with the Company or the Company's Board of Directors (the Board").On January 25, 2023 the Board appointed existing director Rhea Posedel to the Corporate Governance andNominating Committee, replacing Mr. Rosati in this position.
Valuation Update With 7 Day Price Move • Jan 28Investor sentiment improves as stock rises 27%After last week's 27% share price gain to €32.03, the stock trades at a trailing P/E ratio of 79.4x. Average forward P/E is 17x in the Semiconductor industry in Germany. Total returns to shareholders of 1,595% over the past three years.
Recent Insider Transactions • Jan 13Independent Director recently sold €381k worth of stockOn the 10th of January, Geoffrey Scott sold around 15k shares on-market at roughly €25.41 per share. This transaction amounted to 4.6% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger sale from another insider worth €1.7m. Insiders have been net sellers, collectively disposing of €4.3m more than they bought in the last 12 months.
Valuation Update With 7 Day Price Move • Jan 12Investor sentiment improved over the past weekAfter last week's 60% share price gain to €25.95, the stock trades at a trailing P/E ratio of 62.9x. Average forward P/E is 15x in the Semiconductor industry in Germany. Total returns to shareholders of 1,492% over the past three years.
お知らせ • Jan 06Aehr Test Systems Reiterates Revenue Guidance for the Fiscal Year Ending May 31, 2023Aehr Test Systems reiterated revenue guidance for the fiscal year ending May 31, 2023. For the fiscal year ending May 31, 2023, Aehr is reiterating its previously provided guidance for total revenue to be $60 million to $70 million, with strong profit margins similar to last fiscal year. Aehr also continues to expect bookings to grow faster than revenues in fiscal 2023 as the ramp in demand for silicon carbide in electric vehicles increases exponentially throughout the decade.
Reported Earnings • Jan 06Second quarter 2023 earnings released: EPS: US$0.14 (vs US$0.027 in 2Q 2022)Second quarter 2023 results: EPS: US$0.14 (up from US$0.027 in 2Q 2022). Revenue: US$14.8m (up 54% from 2Q 2022). Net income: US$3.73m (up 420% from 2Q 2022). Profit margin: 25% (up from 7.5% in 2Q 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 38% p.a. on average during the next 3 years, compared to a 8.6% growth forecast for the Semiconductor industry in Germany. Over the last 3 years on average, earnings per share has increased by 106% per year whereas the company’s share price has increased by 105% per year.
お知らせ • Dec 23Aehr Test Systems to Report Q2, 2023 Results on Jan 05, 2023Aehr Test Systems announced that they will report Q2, 2023 results at 4:00 PM, US Eastern Standard Time on Jan 05, 2023
Recent Insider Transactions • Nov 18President recently sold €1.7m worth of stockOn the 15th of November, Gayn Erickson sold around 70k shares on-market at roughly €24.93 per share. This transaction amounted to 13% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was Gayn's only on-market trade for the last 12 months.
Valuation Update With 7 Day Price Move • Nov 12Investor sentiment improved over the past weekAfter last week's 23% share price gain to €23.61, the stock trades at a forward P/E ratio of 52x. Average forward P/E is 15x in the Semiconductor industry in Germany. Total returns to shareholders of 1,105% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €13.95 per share.
Recent Insider Transactions • Nov 02Vice President of Engineering recently sold €463k worth of stockOn the 28th of October, Donald Richmond sold around 22k shares on-market at roughly €21.12 per share. This transaction amounted to 12% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of €5.2m more than they bought in the last 12 months.
Valuation Update With 7 Day Price Move • Oct 21Investor sentiment improved over the past weekAfter last week's 25% share price gain to €18.30, the stock trades at a forward P/E ratio of 41x. Average forward P/E is 13x in the Semiconductor industry in Germany. Total returns to shareholders of 1,073% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €15.38 per share.
Reported Earnings • Oct 08First quarter 2023 earnings released: EPS: US$0.022 (vs US$0.029 in 1Q 2022)First quarter 2023 results: EPS: US$0.022 (down from US$0.029 in 1Q 2022). Revenue: US$10.7m (up 89% from 1Q 2022). Net income: US$589.0k (down 15% from 1Q 2022). Profit margin: 5.5% (down from 12% in 1Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 35% p.a. on average during the next 2 years, compared to a 8.6% growth forecast for the Semiconductor industry in Germany. Over the last 3 years on average, earnings per share has increased by 98% per year but the company’s share price has increased by 124% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Oct 07+ 1 more updateAehr Test Systems Provides Revenue Guidance for the Fiscal Year Ending May 31, 2023For the fiscal year ending May 31, 2023, Aehr Test Systems is reiterating its previously provided guidance for total revenue to be at least $60 million to $70 million, with strong profit margins similar to last fiscal year. Aehr also continues to expect bookings to grow faster than revenues in fiscal 2023 as the ramp in demand for silicon carbide in electric vehicles increases exponentially throughout the decade.
Valuation Update With 7 Day Price Move • Sep 28Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to €13.46, the stock trades at a trailing P/E ratio of 39.6x. Average forward P/E is 12x in the Semiconductor industry in Germany. Total returns to shareholders of 768% over the past three years.
お知らせ • Sep 24Aehr Test Systems, Annual General Meeting, Oct 18, 2022Aehr Test Systems, Annual General Meeting, Oct 18, 2022, at 16:00 Pacific Daylight. Location: 400 Kato Terrace, Fremont, California 94539 california United States Agenda: To elect seven directors of the company to hold office until the next annual meeting or the election of their successors; to approve an amendment to the company's amended and restated 2006 employee stock purchase plan (the "espp") to increase the number of shares reserved for issuance thereunder by an additional 350,000 shares of common stock of the company ("common stock"); to ratify the selection of BPM LLP as the company’s independent registered public accounting firm for the fiscal year ending May 31, 2023; to approve, on an advisory (non-binding) basis, the compensation of the company’s named executive officers; and to transact such other business as may properly come before the annual meeting or any postponements or adjournments thereof.
お知らせ • Sep 21Aehr Test Systems to Report Q1, 2023 Results on Oct 06, 2022Aehr Test Systems announced that they will report Q1, 2023 results After-Market on Oct 06, 2022
Valuation Update With 7 Day Price Move • Sep 02Investor sentiment deteriorated over the past weekAfter last week's 25% share price decline to €13.39, the stock trades at a trailing P/E ratio of 39.1x. Average forward P/E is 13x in the Semiconductor industry in Germany. Total returns to shareholders of 981% over the past three years.
Reported Earnings • Aug 28Full year 2022 earnings released: EPS: US$0.36 (vs US$0.086 loss in FY 2021)Full year 2022 results: EPS: US$0.36 (up from US$0.086 loss in FY 2021). Revenue: US$50.8m (up 206% from FY 2021). Net income: US$9.45m (up US$11.5m from FY 2021). Profit margin: 19% (up from net loss in FY 2021). Over the next year, revenue is forecast to grow 22%, compared to a 12% growth forecast for the Semiconductor industry in Germany. Over the last 3 years on average, earnings per share has increased by 86% per year but the company’s share price has increased by 148% per year, which means it is tracking significantly ahead of earnings growth.
Valuation Update With 7 Day Price Move • Aug 09Investor sentiment improved over the past weekAfter last week's 27% share price gain to €15.04, the stock trades at a trailing P/E ratio of 42.6x. Average forward P/E is 16x in the Semiconductor industry in Germany. Total returns to shareholders of 1,200% over the past three years.
Recent Insider Transactions • Aug 05Independent Director recently sold €123k worth of stockOn the 2nd of August, Howard Slayen sold around 10k shares on-market at roughly €12.26 per share. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of €13m more than they bought in the last 12 months.
Valuation Update With 7 Day Price Move • Jul 26Investor sentiment improved over the past weekAfter last week's 21% share price gain to €10.45, the stock trades at a trailing P/E ratio of 30.7x. Average forward P/E is 16x in the Semiconductor industry in Germany. Total returns to shareholders of 741% over the past three years.
Reported Earnings • Jul 21Full year 2022 earnings released: EPS: US$0.36 (vs US$0.086 loss in FY 2021)Full year 2022 results: EPS: US$0.36 (up from US$0.086 loss in FY 2021). Revenue: US$50.8m (up 206% from FY 2021). Net income: US$9.45m (up US$11.5m from FY 2021). Profit margin: 19% (up from net loss in FY 2021). Over the next year, revenue is forecast to grow 22%, compared to a 14% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 86% per year but the company’s share price has increased by 96% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Jul 20Aehr Test Systems Provides Earnings Guidance for the Fiscal Year 2023Aehr Test Systems provided earnings guidance for the fiscal year 2023. For the year, the company expected total revenue to be at least $60 million to $70 million, with strong profit margins similar to last fiscal year. Aehr also expects bookings to grow faster than revenues in fiscal 2023 as the ramp in demand for silicon carbide in electric vehicles increases exponentially throughout the decade.
お知らせ • Jul 13Aehr Test Systems to Report Fiscal Year 2022 Results on Jul 19, 2022Aehr Test Systems announced that they will report fiscal year 2022 results at 4:00 PM, US Eastern Standard Time on Jul 19, 2022
Valuation Update With 7 Day Price Move • Jun 03Investor sentiment improved over the past weekAfter last week's 23% share price gain to €8.75, the stock trades at a trailing P/E ratio of 60.9x. Average forward P/E is 17x in the Semiconductor industry in Germany. Total returns to shareholders of 509% over the past three years.
Valuation Update With 7 Day Price Move • May 18Investor sentiment improved over the past weekAfter last week's 15% share price gain to €7.87, the stock trades at a trailing P/E ratio of 53.6x. Average forward P/E is 16x in the Semiconductor industry in Germany. Total returns to shareholders of 470% over the past three years.
お知らせ • Apr 03Aehr Test Systems Appoints Adil Engineer as the Chief Operating Officer, Effective April 6, 2022Aehr Test Systems appointed Adil Engineer as the Company's Chief Operating Officer, effective April 6, 2022. David Fucci, Interim Vice-President of Operations with the Company, will remain through the fiscal year end May 31, 2022 to assist in the transition. Mr. Engineer, age 45, has built a career in operations and supply chain and has been in the semiconductor and medical equipment field for over 20 years. He started his career with semiconductor equipment company KLA-Tencor where he spent 11 years, and also worked at Coherent and Kateeva in positions of increasing responsibility in manufacturing, manufacturing engineering, new product introduction, and supply chain. Most recently he was the Head of Operations at Tecan, a Swiss company manufacturing medical test and diagnostic tools, devices, and solutions, where he oversaw operations for Tecan’s primary site in the US for manufacturing, located in San Jose. Adil has a Bachelor of Science in Chemical Engineering from TKIET, Shivaji University, India, and a Graduate Certificate in Management Science and Engineering from Leland Stanford Jr. University, Stanford, California. Mr. Engineer does not have a family relationship with any member of the Board or any executive officer of the Company, and Mr. Engineer has not been a participant or had an interest in any transaction with the Company that is reportable under Item 404(a) of Regulation S-K.
Reported Earnings • Apr 02Third quarter 2022 earnings released: EPS: US$0.083 (vs US$0.031 loss in 3Q 2021)Third quarter 2022 results: EPS: US$0.083 (up from US$0.031 loss in 3Q 2021). Revenue: US$15.3m (up 190% from 3Q 2021). Net income: US$2.24m (up US$2.98m from 3Q 2021). Profit margin: 15% (up from net loss in 3Q 2021). Over the next year, revenue is forecast to grow 72%, compared to a 16% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 62% per year but the company’s share price has increased by 79% per year, which means it is tracking significantly ahead of earnings growth.
